Literature DB >> 18322953

Liver histology in ICU patients dying from sepsis: a clinico-pathological study.

John Koskinas1, Ilias P Gomatos, Dina G Tiniakos, Nikolaos Memos, Maria Boutsikou, Aspasia Garatzioti, Athanasios Archimandritis, Alexander Betrosian.   

Abstract

AIM: To determine end-stage pathologic changes in the liver of septic patients dying in the intensive care unit.
METHODS: Needle liver biopsies obtained immediately after death from 15 consecutive patients with sepsis and no underlying liver disease were subjected to routine histological examination. Liver function tests and clinical monitoring measurements were also recorded.
RESULTS: Liver biochemistries were increased in the majority of patients before death. Histology of liver biopsy specimens showed portal inflammation in 73.3%, centrilobular necrosis in 80%, lobular inflammation in 66.7%, hepatocellular apoptosis in 66.6% and cholangitis/cholangiolitis in 20% of patients. Mixed hepatitic/cholestatic type of liver injury was observed in 6/15 (40%) patients and hepatitc in 9/15 (60%). Steatosis was observed in 11/15 (73.3%) patients affecting 5%-80% of liver parenchyma. Among the histological features, the presence of portal inflammation in liver biopsy was associated with increased hospitalization in the ICU prior death (P=0.026).
CONCLUSION: Features of hepatitis and steatosis are the main histological findings in the liver in the majority of patients dying from sepsis.

Entities:  

Mesh:

Year:  2008        PMID: 18322953      PMCID: PMC2693687          DOI: 10.3748/wjg.14.1389

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  18 in total

1.  Immunohistochemical characteristics of the liver in patients with peritonitis (early autopsy).

Authors:  N L Lysova; L E Gurevich; O A Trusov; A I Shchegolev; O D Mishnev
Journal:  Bull Exp Biol Med       Date:  2001-11       Impact factor: 0.804

2.  Clinicopathology conferences: inflammation-induced cholestasis.

Authors:  J M Crawford; J L Boyer
Journal:  Hepatology       Date:  1998-07       Impact factor: 17.425

3.  Endotoxin-induced liver hypoxia: defective oxygen delivery versus oxygen consumption.

Authors:  Philip E James; Melanie Madhani; William Roebuck; Simon K Jackson; Harold M Swartz
Journal:  Nitric Oxide       Date:  2002-02       Impact factor: 4.427

Review 4.  Pathophysiology of sepsis.

Authors:  Judith Jacobi
Journal:  Am J Health Syst Pharm       Date:  2002-02-15       Impact factor: 2.637

5.  Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes.

Authors:  L A Cone; D R Woodard; P M Schlievert; G S Tomory
Journal:  N Engl J Med       Date:  1987-07-16       Impact factor: 91.245

6.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

7.  Abnormal bile duct epithelium accompanying septicaemia.

Authors:  M Vyberg; H Poulsen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

Review 8.  Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.

Authors:  R Phillip Dellinger; Jean M Carlet; Henry Masur; Herwig Gerlach; Thierry Calandra; Jonathan Cohen; Juan Gea-Banacloche; Didier Keh; John C Marshall; Margaret M Parker; Graham Ramsay; Janice L Zimmerman; Jean-Louis Vincent; Mitchell M Levy
Journal:  Crit Care Med       Date:  2004-03       Impact factor: 7.598

Review 9.  Histological assessment of cholestasis.

Authors:  Jay H Lefkowitch
Journal:  Clin Liver Dis       Date:  2004-02       Impact factor: 6.126

10.  Bile ductular cholestasis: an ominous histopathologic sign related to sepsis and "cholangitis lenta".

Authors:  J H Lefkowitch
Journal:  Hum Pathol       Date:  1982-01       Impact factor: 3.466

View more
  35 in total

1.  Does inhibition of apolipoprotein B synthesis produce foie gras?

Authors:  Kenneth R Feingold
Journal:  J Lipid Res       Date:  2009-12-30       Impact factor: 5.922

2.  Xuebijing injection alleviates cytokine-induced inflammatory liver injury in CLP-induced septic rats through induction of suppressor of cytokine signaling 1.

Authors:  Ailin Li; Jing Li; Yuhua Bao; Dingshan Yuan; Zhongwei Huang
Journal:  Exp Ther Med       Date:  2016-06-24       Impact factor: 2.447

Review 3.  Hepatosplanchnic circulation in cirrhosis and sepsis.

Authors:  Meghan Prin; Jan Bakker; Gebhard Wagener
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

4.  Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology.

Authors:  Peter A Szabo; Ankur Goswami; Delfina M Mazzuca; Kyoungok Kim; David B O'Gorman; David A Hess; Ian D Welch; Howard A Young; Bhagirath Singh; John K McCormick; S M Mansour Haeryfar
Journal:  J Immunol       Date:  2017-02-20       Impact factor: 5.422

Review 5.  Cholestatic liver (dys)function during sepsis and other critical illnesses.

Authors:  Marc Jenniskens; Lies Langouche; Yoo-Mee Vanwijngaerden; Dieter Mesotten; Greet Van den Berghe
Journal:  Intensive Care Med       Date:  2015-09-21       Impact factor: 17.440

Review 6.  The role of the liver in sepsis.

Authors:  Jun Yan; Song Li; Shulin Li
Journal:  Int Rev Immunol       Date:  2014-03-10       Impact factor: 5.311

7.  Bilirubin in the early course of venovenous extracorporeal membrane oxygenation support for refractory ARDS.

Authors:  Chiara Lazzeri; Manuela Bonizzoli; Giovanni Cianchi; Stefano Batacchi; Marco Chiostri; Giorgio Enzo Fulceri; Laura Tadini Buoninsegni; Adriano Peris
Journal:  J Artif Organs       Date:  2017-08-18       Impact factor: 1.731

8.  Roflumilast reverses polymicrobial sepsis-induced liver damage by inhibiting inflammation in mice.

Authors:  Hongfang Feng; Jiajia Chen; Haitao Wang; Yufang Cheng; Zhengqiang Zou; Qiuping Zhong; Jiangping Xu
Journal:  Lab Invest       Date:  2017-06-26       Impact factor: 5.662

9.  'Liver function tests' on the intensive care unit: a prospective, observational study.

Authors:  S J Thomson; M L Cowan; I Johnston; S Musa; M Grounds; T M Rahman
Journal:  Intensive Care Med       Date:  2009-06-10       Impact factor: 17.440

Review 10.  [Abnormal liver function tests in the intensive care unit].

Authors:  A Koch; K Streetz; J Tischendorf; C Trautwein; F Tacke
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-10       Impact factor: 0.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.